Automatic Data Processing (ADP) has been widely discussed in recent bio-tech news. The company is set to go
ex-dividend soon, and offers a decent 2.2% yield. Numerous investors are showing increasing interest in the company, with Morningstar Investment Services and Seven Eight Capital buying significant stock holdings. Envestnet Asset Management and Rafferty Asset Management also hold considerable positions. Analysts note that ADP's recent performance could be linked to its favourable financial prospects. The company outperforms in the stock market and appears to be a popular choice amongst options traders.
However, few entities are reducing their stakes, including the American International Group, Northern Trust Corp, and KBC Group. Despite this, the company surpassed analyst revenue and earnings estimates in Q3 of fiscal year 2024, suggesting strong financial health. Amidst this, the company's shares have grown by 73% over the past five years. Experts suggest this success is due to ADP's wise use of debt and a strong U.S. labor market. However, some believe the company's popularity with investors may be threatened by overpricing. Regardless, most analysts consider ADP a safe, dividend-yielding stock.
Automatic Data Processing ADP News Analytics from Mon, 28 Aug 2023 07:00:00 GMT to Sun, 09 Jun 2024 13:36:31 GMT -
Rating 8
- Innovation 6
- Information 7
- Rumor -3
